NO981537D0 - Fremgangsmåte for fremstilling av antimalariamedikamenter - Google Patents

Fremgangsmåte for fremstilling av antimalariamedikamenter

Info

Publication number
NO981537D0
NO981537D0 NO981537A NO981537A NO981537D0 NO 981537 D0 NO981537 D0 NO 981537D0 NO 981537 A NO981537 A NO 981537A NO 981537 A NO981537 A NO 981537A NO 981537 D0 NO981537 D0 NO 981537D0
Authority
NO
Norway
Prior art keywords
preparation
antimalarial drugs
antimalarial
drugs
Prior art date
Application number
NO981537A
Other languages
English (en)
Other versions
NO981537L (no
NO313285B1 (no
Inventor
Cletus Onwuzurike Ugwuegbulam
James Edward Foy
Original Assignee
Smithkline Beecham Plc
Smithkline Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Smithkline Corp filed Critical Smithkline Beecham Plc
Publication of NO981537L publication Critical patent/NO981537L/no
Publication of NO981537D0 publication Critical patent/NO981537D0/no
Publication of NO313285B1 publication Critical patent/NO313285B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/18Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/40Nitrogen atoms attached in position 8
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19981537A 1995-10-13 1998-04-03 Fremgangsmåte for fremstilling av forbindelser som er nyttige for antimalariamedikamenter, samt mellomprodukter forfremgangsmåten NO313285B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9521004.3A GB9521004D0 (en) 1995-10-13 1995-10-13 Process
PCT/EP1996/004433 WO1997013753A1 (en) 1995-10-13 1996-10-11 Process for the preparation of anti-malarial drugs

Publications (3)

Publication Number Publication Date
NO981537L NO981537L (no) 1998-04-03
NO981537D0 true NO981537D0 (no) 1998-04-03
NO313285B1 NO313285B1 (no) 2002-09-09

Family

ID=10782264

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19981537A NO313285B1 (no) 1995-10-13 1998-04-03 Fremgangsmåte for fremstilling av forbindelser som er nyttige for antimalariamedikamenter, samt mellomprodukter forfremgangsmåten

Country Status (28)

Country Link
US (1) US6479660B1 (no)
EP (1) EP0871616B1 (no)
JP (1) JP4083803B2 (no)
KR (1) KR100453256B1 (no)
CN (1) CN1147475C (no)
AR (1) AR004015A1 (no)
AT (1) ATE214372T1 (no)
AU (1) AU709333B2 (no)
BR (1) BR9611010A (no)
CA (1) CA2231633C (no)
CZ (1) CZ290380B6 (no)
DE (1) DE69619863T2 (no)
DK (1) DK0871616T3 (no)
ES (1) ES2170874T3 (no)
GB (1) GB9521004D0 (no)
HK (1) HK1016180A1 (no)
HU (1) HUP9900739A3 (no)
IL (1) IL124060A (no)
NO (1) NO313285B1 (no)
NZ (1) NZ320209A (no)
PL (1) PL186055B1 (no)
PT (1) PT871616E (no)
SA (1) SA97170574B1 (no)
SI (1) SI0871616T1 (no)
TR (1) TR199800637T2 (no)
TW (1) TW450950B (no)
WO (1) WO1997013753A1 (no)
ZA (1) ZA968550B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08276712A (ja) * 1995-04-05 1996-10-22 Masao Tsuji チュ−ブレススパイクタイヤ
GB0210150D0 (en) * 2002-05-03 2002-06-12 Smithkline Beecham Plc Process
PL1924558T3 (pl) * 2005-09-12 2010-07-30 Council Scient Ind Res Przeciwmalaryczne addukty Baylisa Hillmana oraz proces ich wywarzania
WO2007127930A2 (en) * 2006-04-28 2007-11-08 Kansas State University Research Foundation Compounds affecting gap junction activity
GB0620005D0 (en) 2006-10-10 2006-11-22 Glaxo Group Ltd Compounds
US20090076072A1 (en) * 2007-09-14 2009-03-19 Protia, Llc Deuterium-enriched tafenoquine
ES2453206B1 (es) 2013-09-25 2015-01-12 Thyssenkrupp Elevator Innovation Center, S.A. Sistema de tracción para un sistema de transporte
CN113248431A (zh) * 2021-05-21 2021-08-13 重庆医药高等专科学校 一种磷酸伯氨喹的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431807A (en) * 1980-06-12 1984-02-14 The United States Of America As Represented By The Secretary Of The Army 4-Methyl-5-(unsubstituted and substituted phenoxy)-6-methoxy-8-(aminoalkylamino)quinolines
US4617394A (en) * 1985-10-15 1986-10-14 The United States Of America As Represented By The Secretary Of The Army 4-methyl-5-(unsubstituted and substituted phenoxy)-2,6-dimethoxy-8-(aminoalkylamino) quinolines

Also Published As

Publication number Publication date
EP0871616A1 (en) 1998-10-21
HUP9900739A2 (hu) 1999-09-28
ES2170874T3 (es) 2002-08-16
KR100453256B1 (ko) 2004-12-17
HK1016180A1 (en) 1999-10-29
NZ320209A (en) 1999-08-30
AU709333B2 (en) 1999-08-26
CA2231633A1 (en) 1997-04-17
JP4083803B2 (ja) 2008-04-30
DE69619863D1 (de) 2002-04-18
NO981537L (no) 1998-04-03
CN1199395A (zh) 1998-11-18
ATE214372T1 (de) 2002-03-15
KR19990064210A (ko) 1999-07-26
DE69619863T2 (de) 2002-11-21
DK0871616T3 (da) 2002-07-01
JPH11513399A (ja) 1999-11-16
GB9521004D0 (en) 1995-12-13
AU7291096A (en) 1997-04-30
WO1997013753A1 (en) 1997-04-17
TW450950B (en) 2001-08-21
PL326194A1 (en) 1998-08-31
SI0871616T1 (en) 2002-12-31
EP0871616B1 (en) 2002-03-13
HUP9900739A3 (en) 1999-11-29
US6479660B1 (en) 2002-11-12
CA2231633C (en) 2006-10-03
CZ290380B6 (cs) 2002-07-17
IL124060A (en) 2003-07-31
CN1147475C (zh) 2004-04-28
ZA968550B (en) 1998-04-14
SA97170574B1 (ar) 2006-09-25
CZ110398A3 (cs) 1998-09-16
TR199800637T2 (xx) 1998-07-21
BR9611010A (pt) 1999-07-13
PT871616E (pt) 2002-07-31
AR004015A1 (es) 1998-09-30
NO313285B1 (no) 2002-09-09
PL186055B1 (pl) 2003-09-30

Similar Documents

Publication Publication Date Title
NO974557D0 (no) Fremgangsmåte for fremstilling av respirerbare partikler
NO973938L (no) Farmasöytisk preparat av piperidinoalkanolforbindelser
NO961006L (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
TR199600857A2 (tr) Nikotinamidin hazirlanmasi icin islem.
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO981537D0 (no) Fremgangsmåte for fremstilling av antimalariamedikamenter
FI964229A (fi) Menetelmä doksorubisiinin valmistamiseksi
NO304110B1 (no) FremgangsmÕte for fremstilling av glutardialdehyd
NO963432D0 (no) Fremgangsmåte for fremstilling av dimetyldiklorsilan
NO20003393D0 (no) FremgangsmÕte for fremstilling av en farmasøytisk formulering
NO980384L (no) Fremgangsmåte for fremstilling av fastdoseformer av svært lav-dose legemidler
NO981798D0 (no) FremgangsmÕte for fremstilling av faste legemiddelformer
NO973835L (no) Fremgangsmåte for fremstilling av lorakarbefmonohydrat
NO974747D0 (no) Fremgangsmåte for fremstilling av streptograminer
FI974002A0 (fi) Menetelmä ranitidiinihydrokloridi 1 muodon valmistamiseksi
NO962809D0 (no) Fremgangsmåte for fremstilling av N-substituerte 4-ketoprolinderivater
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO961004D0 (no) Fremgangsmåte for fremstilling av N-acetyl-D-glukosamin-deacetylase
NO994557D0 (no) Fremgangsmaate for fremstilling av arylaminotriazolopyridiner
FI960790A (fi) Menetelmä fluoreenibisfenolin valmistamiseksi
NO963174D0 (no) Fremgangsmåte for fremstilling av isovanillin
NO20002476D0 (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees